■研究将患者的偏好纳入治疗结果的影响,突出了其对关键方面的影响,如降低辍学率和提高有效性。认识到个人有权参与有关其治疗方法的决定强调了研究治疗偏好和影响这些选择的因素的重要性。
■本研究旨在确定治疗偏好(心理,药理学,或组合)在患者样本中,并辨别影响这些偏好的社会心理和临床因素。
■共有2,133名在社区精神卫生部门接受护理的人完成了对焦虑抑郁症状的评估,社会和职业适应,以及他们的治疗偏好。数据分析采用SPSS,通过描述性统计,卡方检验,应用了单向方差分析。
■治疗的偏好分布如下:联合(49.8%),心理(33%),和药理学(10.6%)。诊断等因素,抑郁和焦虑症状的严重程度,和功能影响与中等效应大小的治疗偏好相关。同时,与所选治疗相关的各种社会人口统计学因素,虽然效果大小较弱。
■对联合治疗有明显的偏好。心理治疗的意义是显而易见的,因为五分之四的参与者在他们的选择中更喜欢他们。解决这些偏好要求在更广泛的心理健康处方自由背景下进行探索。
UNASSIGNED: Studies examining the effects of incorporating patients\' preferences into treatment outcomes highlight their impact on crucial aspects such as reduced dropout rates and enhanced effectiveness. Recognizing individuals\' rights to participate in decisions about their treatments underscores the importance of studying treatment preferences and the factors influencing these choices.
UNASSIGNED: This study aims to identify treatment preferences (psychological, pharmacological, or combined) among a sample of patients and to discern the psychosocial and clinical factors influencing these preferences.
UNASSIGNED: A total of 2,133 individuals receiving care at a community mental health unit completed assessments on anxious-depressive symptoms, social and occupational adjustment, and their treatment preference. Data analysis was conducted using SPSS, with descriptive statistics, Chi-square tests, and one-way ANOVA applied.
UNASSIGNED: Preferences for treatments were distributed as follows: Combined (49.8%), psychological (33%), and pharmacological (10.6%). Factors such as diagnosis, severity of depressive and anxious symptoms, and functional impact were related to treatment preference with a moderate effect size. Meanwhile, various sociodemographic factors correlated with the selected treatment, though with a weak effect size.
UNASSIGNED: There is a pronounced preference for combined treatments. The significance of psychological treatments is evident, as four out of five participants favored them in their choices. Addressing these preferences calls for an exploration within the broader context of prescription freedom in mental health.